NTMir’s mission is to save and improve lives through research, education, early detection, and improved treatments for people with pulmonary nontuberculous mycobacterial (NTM) disease.

Latest News

View More

FDA Workshop on the Development of Antibiotic Therapies for NTM

On April 8th, 2019 from 8:30 am to 5 pm the FDA will hold a public workshop entitled “Development of Antibacterial Drugs for the Treatment of Nontuberculous...
Read More

NTM Patient Preferences Survey

On April 8th, 2019 the U.S. Food & Drug Administration will host a public workshop on the development of antibacterial drugs for the treatment of nontuberculous mycobacterial...
Read More

Register today for the 2019 Physician/Patient Conference!

Registration is now open for the 2019 Physician/Patient Conference!
Read More

Corporate Sponsor

Stay Informed

Sign up for NTMir's news releases